Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome

Published:2020-09 Issue: Volume:346 Page:577308
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Garcia-Estrada Christian,Casallas-Vanegas Adriana,Zabala-Angeles Indhira,Gomez-Figueroa Enrique,Rivas-Alonso Verónica,Flores-Rivera José

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference11 articles.

1. Tocilizumab for severe refractory neuro-Behçet: three cases IL-6 blockade in neuro-Behçet;Addimanda;Semin. Arthritis Rheum.,2015

2. Treating the different phenotypes of Behçet’s syndrome;Bettiol;Front. Immunol.,2019

3. Infliximab for patients with neuro-Behcet’s disease: case series and literature review;Borhani-Haghighi;Clin. Rheumatol.,2011

4. Phenotypic characteristics of B cells in Behcet’s disease:increased activity in B cell subsets;Eksioglu-Demiralp;J. Rheumatol.,1999

5. Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study);Fereydoun;Int. J. Rheum. Dis.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic approach to central nervous system involvement of Behçet's disease;Seminars in Arthritis and Rheumatism;2023-08

2. Intestinal Behcet’s Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents;International Journal of Molecular Sciences;2023-05-03

3. B Cells at the Cross-Roads of Autoimmune Diseases and Auto-Inflammatory Syndromes;Cells;2022-12-12

4. Successful Treatment of Recurrent Oral and Genital Ulcers in Behcet's Disease with Rituximab;INDIAN J DERMATOL;2022

5. B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet’s Disease;Cells;2022-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3